Detalles de la búsqueda
1.
Risk factors for joint symptoms in postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.
Int J Clin Oncol
; 21(2): 262-269, 2016 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-26411314
2.
Influence of body mass index on clinicopathological factors including estrogen receptor, progesterone receptor, and Ki67 expression levels in breast cancers.
Int J Clin Oncol
; 19(3): 467-72, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-23821234
3.
Body mass index and menopausal disorders during menopause affect vasomotor symptoms of postmenopausal Japanese breast cancer patients treated with anastrozole: a prospective multicenter cohort study of patient-reported outcomes.
Breast Cancer
; 24(4): 528-534, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27730528
4.
C4.4A highly expressed in HER2-positive human breast cancers may indicate a good prognosis.
Breast Cancer
; 22(4): 366-73, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23918676
5.
Association of body mass index with risk of luminal A but not luminal B estrogen receptor-positive and HER2-negative breast cancer for postmenopausal Japanese women.
Breast Cancer
; 22(4): 399-405, 2015 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24000037
6.
Biological characteristics of luminal subtypes in pre- and postmenopausal estrogen receptor-positive and HER2-negative breast cancers.
Breast Cancer
; 21(1): 52-7, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22359195
Resultados
1 -
6
de 6
1
Próxima >
>>